infection, causing an immunological response. These were a high incidence of anticomplementary activity in sera, with higher levels in the first paired sera, from individual patients and from the results of electronmicroscopy showing "complexes" in the serum. It is now established that anticomplementary activity is a simple test showing the presence of immune complexes in the serum. In fact, the presence of anticomplementary activity was the first suggestion that immune complexes could be present in the circulation with Australia antigen (Shulman and Barker, 1969) .
Lymphocyte cultures was decided on because of the relative ease with which lymphocytes from conditions such as certain lymphoproliferative disorders and infectious mononucleosis proliferate in vitro. Though this is possible in some normal people massive numbers of lymphocytes are required. In the present study only 4 and 20 X 106 lymphocytes were used in separate cultures and yet in one of the sets of cultures proliferation readily occurred, permitting subcultures to be made in which proliferation continued. The usefulness of this investigation was limited by the disappointing loss of the cultures through a technical mishap at a relatively early stage. Some of the proliferating lymphocytes had, however, been examined by electronmicroscopy without providing any positive information.
This report of the syndrome of epidemic neuromyasthenia adds to the literature on a puzzling condition, since its aetiology remains unknown. Though it seems to be somewhat uncommon the attack rate in communities in which it has been described is high. Perhaps it is uncommon because the broad spectrum of the relatively mild symptoms may not be readily recognizable in the general community, whereas in relatively restricted populations departures from communal norms are more easily recognized (Graybill et al., 1972) . We have used the term "epidemic neuromyasthenia" for this unexplained illness for the same reasons as Henderson and Shelokov (1959) . It resembles in many ways outbreaks they have studied (Shelokov et al., 1957) . This term seems to be the least objectionable in the limits of our present understanding. Acheson (1959) , however, thinks that "benign myalgic encephalomyelitis" is more suitable. Both terms would seem to be acceptable but clearly they are not entirely satisfactory.
Introduction
Since the introduction of pentazocine in 1967 bizarre central nervous system disturbances such as hallucinations, euphoria, and feelings of depersonalization have been reported following its administration (De Nosaquo, 1970; Edison, 1969) and the occurrence of dependence has also been recorded (Hart, 1969; Mungavin, 1969; Sandoval and Wang, 1969; Scholar et al., 1969 ). An investigation was conducted to estimate the frequency with which hospital inpatients receiving pentazocine reported perceptual disturbances (visual, auditory, etc.) which were independent of the appropriate stimuli, and, while it was not possible to match these patients accurately, those receiving analgesics such as dihydrocodeine or methadone were interviewed to determine the frequency of hallucinatory episodes in similar populations. A follow-up study to ascertain whether patients given pentazocine in hospital had become dependent on the drug was also undertaken.
Methods
Pilot Study.-Patients receiving oral or intramuscular pentazocine, dihydrocodeine, or methadone were identified by means of a drug prescribing system (Crooks et al., 1965) and were interviewed, using a standard questionnaire, within 36 hours of the last dose concerning the occurrence of various symptoms including unusual psychological phenomena. The opportunity was taken to ask "open-ended" questions which allowed the patient some latitude to talk about recent symptoms.
Prospective Study.-Patients who had received pentazocine, cyclimorph, dihydrocodeine, or pethidine in the preceding 24 hours were selected as before, but by one investigator. The other investigator undertook the interviews but, to eliminate possible bias, did not know which drugs the patients had had.
Follow-up Study.-Patienits who had received pentazocine in hospital over a period of six months were identified by means of a drug information system (Coull et al., 1970) . Three groups of patients with conditions likely to require long-term analgesia were selected and questionnaires were sent to their general practitioners about their analgesic medication.
Results
Pilot Study.-Of 103 patients interviewed 70 had received pentazocine, 28 dihydrocodeine, and 5 methadone. Of the 70 receiving pentazocine seven (10%) experienced perceptual disturbances, two after intramuscular and five after oral administration, and one of the patients receiving dihydrocodeine orally experienced such a disturbance (table I) . Patients who admitted to abnormal perceptions but described them as "dreams" were excluded.
Prospective Study.-Of the 244 patients in'terviewed 132 had received pentazocine, 55 cyclimorph, 30 dihydrocodeine, and 27 pethidine. Nine of the 132 experienced perceptual disturb-ances, six after intramuscular and three after oral administration of petazocine, while only one of the remaining 112 patients, who had received another analgesic, experienced similar episodes (table II) .
Follow-up Study.-Fifty neurosurgical, 39 orthopaedic, and 46 cancer patients were identified and 129 replies were received to the questionnaires sent to their general practitioners. Only 24 patients had received pentazocine after discharve, and two of them had required an increase in dosage. Fifty-one patients had received other analgesic medication and six expressed a preference for a particular drug. Four of the 24 patients receiving pentazocine expressed a preference for it.
Discussion and Conclusions In a social climate in which hallucinogens are increasingly used it is important to establish the freauency with which such effects are produced. An attempt was therefore made to determine the occurrence of unusual psycholoeical phenomena in hospital inpatients, using the drug monitoring facilities of the Aberdeen and Dundee hoepitals. While 18 cases of perceptual disturbance were detected by the monitoring team (tables I and II), only one of these was spontaneouslv reported bv a hospital doctor to the Committee on Safety of Medicines. Preexisting monitoring facilities for investigating and assessing the clinical significance of suspected adverse drug reactions as soon as they occur are therefore of considerable importance. In the present study we achieved a result within a period of six weeks.
Though the study supported the association of pentazocine with perceptual disturbances, and showed the incidence to be between 7% and 100/,, the patients received the drue in normal therapeutic doses. It would therefore be uniustified to assume that the incidence would be the same if a hirher dosage were taken. It is of interest to note that the disturbances occurred as often after oral as after intramuscular administration of the drug.
In general, visual disturbances were more common than auditory, though some patient's experienced both simultaneously. There was also a wide spectrum of reaotions from those of pleasure to those of intense dislike. Pentazocine is commonly prescribed for outpatients (569,000 prescriptions in 1970) , and even if only 7% of them experience hallucinations these will probably soon occur in a patient who has already abused other drugs for their psychotropic effects. Our preliminary investigation of outpatients who had received pentazocine in hospital provided little evidence that the patients had become habitu- Some six years later it seemed worth while to re-examine the pattern of admissions to the eight-bed respiratory intensive care unit at the Glasgow Royal Infirmary to see if there had been any significant changes in the pattern of admissions, the incidence of certain conditions, and morbidity. The results are reported here.
The Glasgow Royal Infirmary is a major teaching hospital with a large emergency commitment for both medical and surgical
